Gynecology, gynecologic oncology, cardiology and rare diseases are areas where there will be changes regarding treatment as a result of the new list of reimbursed drugs coming into effect. Patients have gained access to reimbursement for 7 therapies in oncology indications and 26 non-oncology indications. 8 of these are for rare diseases.
In terms of rare diseases, there will be:
- Revising the provisions of the SMA drug program for Zolgensma gene therapy,
- Expanding access to RSV vaccine,
for sick children:
- On SMA until the age of 2,
- For cystic fibrosis up to 1 year of age.
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
